S-Space

Browse

Author

Showing results 1 to 1 of 1

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2024-06	Lorlatinib vs crizotinib in treatment-naïve patients with advanced ALK plus non-small cell lung cancer: 5-year progression-free survival and safety from the CROWN study. Solomon, Benjamin J.; Liu, Geoffrey; Felip, Enriqueta; Mok, Tony S. K.; Soo, Ross Andrew; Mazieres, Julien; Shaw, Alice Tsang; de Marinis, Filippo; Goto, Yasushi; Wu, Yi-Long; Kim, Dong-Wan; Martini, Jean-Francois; Messina, Rossella; Paolini, Jolanda; Polli, Anna; Thomaidou, Despina; Toffalorio, Francesca; Bauer, Todd Michael Journal of Clinical Oncology, Vol.42 No.17_SUPPL, pp.LBA8503-LBA8503	DOI